methylprednisolone hemisuccinate has been researched along with Angioedema in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Good, D; Krishnaiah, B; Lee, J; McLaughlin, D | 1 |
Koutsostathis, N; Vovolis, V | 1 |
Jones, JM; Raval, DG; Reich, KA | 1 |
Jahnke, HK | 1 |
4 other study(ies) available for methylprednisolone hemisuccinate and Angioedema
Article | Year |
---|---|
Double trouble: tPA-induced angioedema.
Topics: Administration, Intravenous; Aged; Airway Management; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Bradykinin; Diphenhydramine; Endoscopy; Humans; Male; Methylprednisolone Hemisuccinate; Paresis; Tissue Plasminogen Activator; Tongue Diseases; Treatment Outcome | 2017 |
Severe immunoglobulin E-mediated anaphylaxis to intravenous methylprednisolone succinate in a patient who tolerated oral methylprednisolone.
Topics: Administration, Oral; Adult; Anaphylaxis; Angioedema; Bronchial Spasm; Cross Reactions; Drug Hypersensitivity; Epitopes; Female; Humans; Immunoglobulin E; Injections, Intravenous; Methylprednisolone Hemisuccinate; Pruritus; Skin Tests | 2009 |
Angioedema in a 47-year-old woman with hypocomplementemic urticarial vasculitis syndrome.
Topics: Angioedema; Autoantibodies; Complement System Proteins; Epinephrine; Female; Humans; Infusions, Intravenous; Methylprednisolone Hemisuccinate; Middle Aged; Rare Diseases; Risk Assessment; Severity of Illness Index; Syndrome; Treatment Outcome; Urticaria; Vasculitis | 2012 |
An 89-year-old woman with angioedema during t-PA infusion for acute ischemic stroke.
Topics: Aged; Aged, 80 and over; Angioedema; Anti-Inflammatory Agents; Brain Ischemia; Diphenhydramine; Emergency Treatment; Female; Fibrinolytic Agents; Histamine H1 Antagonists; Humans; Intubation, Intratracheal; Methylprednisolone Hemisuccinate; Stroke; Time Factors; Tissue Plasminogen Activator | 2003 |